RXRX — Recursion Pharmaceuticals, Inc. stock price, charts and financials

QT33Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
3.26
+0.04+1.39%
OverviewShort InterestFilings
RXRXQT33Recursion Pharmaceuticals, Inc.·NASDAQ
3.26+1.39%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 20264Statement of changes in beneficial ownership
Aug 05, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 09, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 18, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
#1 / 25 of 519
Page
▼
/ 21